Stephan Kremers - Concepedia

Author

Stephan Kremers

Also Known As

Claus-Henning Koehne, L Kanz, Martin Wernli, S Kremers, S P Kremers, S. Kremers, Stephan Kremers, T. Steinmetz, U. Vehling-Kaiser, W Fiedler

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University Caritas-Krankenhaus St. Josef Heinrich Heine University Düsseldorf University Hospital Ulm Johannes Gutenberg University Mainz

About

Stephan Kremers is an author at Heidelberg University specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1K
2	Engineering	5	5	1.2K
3	Health Sciences	3	3	749
4	Natural Sciences	1	1	43
5	Public Health	1	1	37

Stephan Kremers

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Resonant bonding in crystalline phase-change materials K.V. Shportko, Stephan Kremers, Michael Woda, Nature Materials Materials ScienceEngineeringCrystal MaterialResonant BondingCondensed Matter Physics	2008	1.1K
Treatment of Older Patients with Mantle-Cell Lymphoma Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, New England Journal of Medicine	2012	511
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post, The Lancet Oncology Radiation TherapyGastrointestinal OncologyMedicineAdvanced Rectal CancerCancer Treatment	2012	501
Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A Richard F. Schlenk, Konstanze Döhner, Silja Mack, Journal of Clinical Oncology	2010	229
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka, Blood	2013	178
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, Blood	2007	168
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia Richard F Schlenk, Stefan Fröhling, Frank Hartmann, Leukemia Hematological MalignancyOncologyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia	2004	168
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial Judith Trotman, Sally F. Barrington, David Belada, The Lancet Oncology Lymphoid NeoplasiaEnd-of-induction Pet ResponseMedicinePrognostic ValueFollicular Lymphoma	2018	152
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma Boris Böll, Henning Bredenfeld, Helen Görgen, Blood	2011	95
Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, Leukemia Hematological MalignancyChronic Myeloid LeukemiaHealth SciencesMedicineHematology	2003	80

Page 1